SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-040173
Filing Date
2020-08-14
Accepted
2020-08-14 07:29:24
Documents
69
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imra-10q_20200630.htm 10-Q 2525943
2 EX-10.1 imra-ex101_216.htm EX-10.1 69423
3 EX-31.1 imra-ex311_6.htm EX-31.1 19384
4 EX-31.2 imra-ex312_7.htm EX-31.2 19622
5 EX-32.1 imra-ex321_9.htm EX-32.1 9845
6 EX-32.2 imra-ex322_8.htm EX-32.2 10046
  Complete submission text file 0001564590-20-040173.txt   7102128

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT imra-20200630.xml EX-101.INS 1282853
8 XBRL TAXONOMY EXTENSION SCHEMA imra-20200630.xsd EX-101.SCH 44724
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imra-20200630_cal.xml EX-101.CAL 38813
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imra-20200630_def.xml EX-101.DEF 145783
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20200630_lab.xml EX-101.LAB 350762
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20200630_pre.xml EX-101.PRE 294482
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39247 | Film No.: 201101352
SIC: 2834 Pharmaceutical Preparations